JP2011511090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011511090A5 JP2011511090A5 JP2010546007A JP2010546007A JP2011511090A5 JP 2011511090 A5 JP2011511090 A5 JP 2011511090A5 JP 2010546007 A JP2010546007 A JP 2010546007A JP 2010546007 A JP2010546007 A JP 2010546007A JP 2011511090 A5 JP2011511090 A5 JP 2011511090A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cells
- growth factor
- layer
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2699008P | 2008-02-07 | 2008-02-07 | |
| US9322808P | 2008-08-29 | 2008-08-29 | |
| PCT/US2009/033275 WO2009100253A1 (en) | 2008-02-07 | 2009-02-05 | Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011511090A JP2011511090A (ja) | 2011-04-07 |
| JP2011511090A5 true JP2011511090A5 (https=) | 2013-03-28 |
Family
ID=40939054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010546007A Ceased JP2011511090A (ja) | 2008-02-07 | 2009-02-05 | 治療用タンパク質をコードする発現ベクターの硝子体内投与による光受容体のレスキュー方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8242093B2 (https=) |
| EP (1) | EP2247258A4 (https=) |
| JP (1) | JP2011511090A (https=) |
| CN (1) | CN101980668A (https=) |
| AU (1) | AU2009212309B2 (https=) |
| CA (1) | CA2713755A1 (https=) |
| WO (1) | WO2009100253A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009212309B2 (en) * | 2008-02-07 | 2014-04-03 | Ceregene, Inc. | Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein |
| GB201103062D0 (en) * | 2011-02-22 | 2011-04-06 | Isis Innovation | Method |
| CN103459593A (zh) * | 2011-02-25 | 2013-12-18 | 独立行政法人理化学研究所 | 视网膜色素上皮细胞片层的生产方法 |
| EP2872183B1 (en) * | 2012-07-11 | 2018-09-26 | The Trustees Of The University Of Pennsylvania | Aav-mediated gene therapy for rpgr x-linked retinal degeneration |
| WO2015044704A1 (en) * | 2013-09-30 | 2015-04-02 | Sanofi | Use of neuroglobin agonist for preventing or treating mitochondrial rcci and/or rcciii deficiency disease |
| AU2014359136B2 (en) * | 2013-12-06 | 2020-06-25 | Centre Hospitalier Universitaire De Montpellier | Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject |
| WO2016164920A1 (en) * | 2015-04-09 | 2016-10-13 | Cornell University | Gene therapy to prevent reactions to allergens |
| AU2016363830C1 (en) * | 2015-12-04 | 2022-03-24 | Centre National De La Recherche Scientifique | Promoters and uses thereof |
| AU2017256910B2 (en) * | 2016-04-29 | 2022-04-07 | Centre National De La Recherche Scientifique | Optogenetic visual restoration using Chrimson |
| PL239642B1 (pl) * | 2018-08-16 | 2021-12-20 | Pomorski Univ Medyczny W Szczecinie | Kompozycja do doszklistkowego podawania białka leczniczego |
| CA3199230A1 (en) | 2020-10-22 | 2022-04-28 | Visgenx, Inc. | Elovl2 constructs for human gene therapy |
| AU2023390868A1 (en) * | 2022-12-05 | 2025-06-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Pigment epithelium-derived factor peptides and use for treating retinal degeneration |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932479A (en) | 1988-09-26 | 1999-08-03 | Auburn University | Genetic engineering of plant chloroplasts |
| DE69817180D1 (de) * | 1997-06-11 | 2003-09-18 | Acorda Therapeutics Hawthorne | Zns neuroregenerative zusammensetzungen und deren verwendungen |
| JP2002534139A (ja) * | 1999-01-05 | 2002-10-15 | マサチューセッツ・アイ・アンド・イア・インファーマリー | 網膜と脈絡膜への経強膜徐放性薬剤標的送達 |
| US6943153B1 (en) * | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| AU3755900A (en) * | 1999-03-15 | 2000-10-04 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| AU2001241809A1 (en) | 2000-02-29 | 2001-09-12 | Auburn University | Genetic engineering of drought tolerance via a plastid genome |
| CA2402066C (en) | 2000-03-01 | 2015-09-29 | Auburn University | Plastid transformation vectors for expressing human proteins in plants |
| US7354760B2 (en) | 2001-12-26 | 2008-04-08 | University Of Central Florida Research Foundation, Inc. | Expression of protective antigens in transgenic chloroplasts |
| AU2003253781A1 (en) | 2002-07-03 | 2004-01-23 | University Of Central Florida | Expression of human interferon in transgenic chloroplasts |
| US20100172871A1 (en) | 2005-02-17 | 2010-07-08 | Flannery John G | Muller Cell Specific Gene Therapy |
| US20060188481A1 (en) * | 2005-02-22 | 2006-08-24 | Saitama Medical School | Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder |
| CA2598029A1 (en) | 2005-02-24 | 2006-10-05 | The Scripps Research Institute | Isolated myeloid-like bone marrow cell populations and methods of treatment therewith |
| US20080274143A1 (en) | 2005-05-27 | 2008-11-06 | Henry Daniell | Chloroplasts Engineering to Express Pharmaceutical Proteins |
| AU2009212309B2 (en) * | 2008-02-07 | 2014-04-03 | Ceregene, Inc. | Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein |
-
2009
- 2009-02-05 AU AU2009212309A patent/AU2009212309B2/en not_active Ceased
- 2009-02-05 JP JP2010546007A patent/JP2011511090A/ja not_active Ceased
- 2009-02-05 CN CN2009801043603A patent/CN101980668A/zh active Pending
- 2009-02-05 CA CA2713755A patent/CA2713755A1/en not_active Abandoned
- 2009-02-05 US US12/366,596 patent/US8242093B2/en not_active Expired - Fee Related
- 2009-02-05 WO PCT/US2009/033275 patent/WO2009100253A1/en not_active Ceased
- 2009-02-05 EP EP09707354A patent/EP2247258A4/en not_active Withdrawn
-
2011
- 2011-08-17 US US13/212,078 patent/US8420619B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011511090A5 (https=) | ||
| JP7182873B2 (ja) | 多重ベクターシステム及びその使用 | |
| RU2018142768A (ru) | Варианты капсидов аденоассоциированного вируса и способы их применения | |
| HRP20211024T1 (hr) | Aav vektori za gensku terapiju mrežnice i cns-a | |
| UA130154C2 (uk) | Спосіб безклітинного одержання днк-вектора з замкненими кінцями | |
| JP2020532981A (ja) | 修飾型閉端ｄｎａ（ｃｅｄｎａ） | |
| EP3387137A1 (en) | TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs) | |
| JP2015523379A5 (https=) | ||
| HRP20171334T1 (hr) | Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe | |
| RU2017121593A (ru) | Векторы aav, нацеленные на центральную нервную систему | |
| CN113301956B (zh) | 控制器官功能的基因治疗方法 | |
| JP2017506521A5 (https=) | ||
| Hellstrom et al. | Retinal ganglion cell gene therapy and visual system repair | |
| JP7289306B2 (ja) | 網膜障害を治療するための組成物及び方法 | |
| JP2021511030A5 (https=) | ||
| IL308645A (en) | Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies | |
| CN112029773B (zh) | 编码bdnf的核酸及其应用 | |
| JP2022511227A (ja) | Ｉｇｆ－１異型体を発現させるｄｎａコンストラクトを用いた神経病症の治療 | |
| CN115927472A (zh) | 一种抗vegf抗体体内表达系统的构建和应用 | |
| US12472270B2 (en) | Methods and compositions for reprogramming Müller Glia | |
| CA3228666A1 (en) | Compositions and methods for transgene expression | |
| KR20210130578A (ko) | 폐섬유증 치료 또는 예방을 위한 세포 치료제 조성물 | |
| EA049462B1 (ru) | Способы генной терапии для контроля функции органов | |
| US20210308169A1 (en) | Methods and compositions for treatment of retinal degenerative diseases | |
| RU2021101475A (ru) | Вирионы аденоассоциированного вируса с вариантным капсидом и способы их использования |